What are the symptoms of Ureaplasma urealyticum infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Symptoms of Ureaplasma urealyticum Infection

Ureaplasma urealyticum most commonly causes urethritis with mucoid or purulent urethral discharge and burning during urination (dysuria), though many infections are completely asymptomatic. 1

Primary Clinical Manifestations

In Men with Urethritis

According to CDC guidelines, when U. urealyticum causes nongonococcal urethritis (accounting for 20-40% of NGU cases), the characteristic symptoms include:

  • Mucoid or purulent urethral discharge (most common presenting sign) 1
  • Dysuria (burning during urination) 1, 2
  • Urethral pruritis (itching) 3
  • Hypogastric pain 2

Critical caveat: Asymptomatic infections are extremely common - many patients harbor U. urealyticum without any symptoms whatsoever. 1, 3

In Women

The presentation in women is less well-defined in the guidelines, but research evidence shows:

  • Chronic urinary symptoms including frequency and urgency 4
  • Abnormal vaginal discharge (when causing mucopurulent cervicitis) 1
  • Abnormal vaginal bleeding (particularly post-coital) 1
  • Many women remain asymptomatic despite active infection 1

Complications and Associated Symptoms

In Immunocompetent Patients

When complications develop, additional symptoms may include:

  • Epididymitis symptoms: scrotal pain, swelling 1, 2
  • Reiter's syndrome manifestations: joint pain, eye inflammation, urethritis triad 1

In Immunocompromised Patients (Critical Recognition)

In immunocompromised individuals (transplant recipients, hypogammaglobulinemia), U. urealyticum can cause severe invasive disease with dramatically different presentations:

  • Altered mental status and hyperammonemia syndrome (occurs in the majority of transplant cases) 5
  • Persistent fever 5
  • Progressive renal failure 6, 7
  • Neurologic symptoms 7
  • Gross hematuria 6
  • Destructive soft tissue lesions that may mimic malignancy 8

Diagnostic Pitfalls

The most important clinical pitfall is that U. urealyticum lacks a cell wall, making it invisible on Gram stain and unable to grow on routine bacterial culture media. 6, 8 This leads to:

  1. Patients initially receiving inadequate empirical antibiotics (beta-lactams are ineffective)
  2. Delayed diagnosis requiring molecular diagnostics (PCR, 16S rRNA sequencing)
  3. Misdiagnosis as "culture-negative" infection or even malignancy in severe cases 8

When to suspect U. urealyticum specifically:

  • Persistent urethritis symptoms despite standard antibiotic therapy 1
  • Culture-negative urethritis with documented pyuria (≥5 WBCs per oil immersion field) 1
  • Tetracycline-resistant NGU requiring extended erythromycin therapy 1
  • Immunocompromised patients with unexplained fever, altered mental status, or hyperammonemia 5, 7

Laboratory Confirmation of Symptoms

Urethritis from U. urealyticum is confirmed by demonstrating urethral inflammation:

  • ≥5 polymorphonuclear leukocytes per oil immersion field on urethral smear 1
  • Positive leukocyte esterase test on first-void urine 3
  • ≥10 WBCs per high power field on urine microscopy 3

The 2024 European guidelines note ongoing debate about U. urealyticum's pathogenic role, with recent data suggesting U. urealyticum (but not U. parvum) causes urethritis 9, though routine culture is not recommended due to high colonization rates in asymptomatic individuals 10.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.